A controlled trial of fluoxetine in crack cocaine dependence

Drug and Alcohol Dependence

Volumn 41, Issue 2, 1996, Pages 137-142

  Batki, Steven L ^b   Washburn, Allyson M ^b   Delucchi, Kevin ^b   Jones, Reese T ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

Benzoylecgonine; Cocaine; Fluoxetine; Retention; Treatment

Indexed keywords

BENZOYLECGONINE; COCAINE; FLUOXETINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG EFFICACY; DRUG RETENTION; DRUG USE; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; OUTPATIENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; TREATMENT OUTCOME; URINARY EXCRETION;

EID: 0029899283     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/0376-8716(96)01233-1     Document Type: Article

References (25)

1. American Psychiatrie Association. (1987) Diagnostic and Statistical Manual of Mental Disorders. Third Edition, Revised (DSM-III-R). American Psychiatric Association, Washington, DC.
2. Batki, S., Manfredi, L., Sorensen, J., Jacob, P., Dumontet, R. and Jones. R. (1991) Fluoxetine for cocaine abuse in methadone patients: preliminary findings. In: Problems of Drug Dependence 1990: Proceedings of the 53rd Annual Scientific Meeting, the Committee on Problems of Drug Dependence, (Harris, L.S., ed.). US Government Printing Office, Washington, DC.
3. Batki, S., Manfredi, L., Jacob, P. and Jones, R. (1993) Fluoxetine for cocaine dependence in methadone maintenance: quantitative plasma and urine cocaine/benzoylecgonine concentrations. J. Clin. Psychopharmacol. 13, 243-250.
4. Batki, S., Washburn, A., Manfredi. L., Murphy, J., Herbst, M., Jones, T., Nanda, N., Jacob, P. and Jones, R. (1994) Fluoxetine in primary and secondary cocaine dependence: outcome measured by quantitative benzoylecgonine concentration. In: Problems of Drug Dependence 1993: Proceedings of the 55th Annual Scientific Meeting, the College on Problems of Drug Dependence, (Harris, L.S., ed.). US Government Printing Office, Washington, DC.
5. Carroll, M., Lac, S., Asencio, M. and Kragh, R. (1990) Fluoxetine reduces intravenous cocaine self-administration in rats. Pharmacol. Biochem. Behav. 35, 237-244.
6. Coccaro, E., Astill, J., Herbert, J. and Schut, A. (1990) Fluoxetine treatment of impulsive aggression in DSM-III-R personality disorder patients. J. Clin. Psychopharmacol. 10, 373-375.
7. Covi, L., Hess, J., Kreiter, N. and Haertzen, C. (1994) Three models for the analysis of a fluoxetine controlled treatment in cocaine abuse. In: Problems of Drug Dependence 1993: Proceedings of the 55th Annual Scientific Meeting, the College on Problems of Drug Dependence, (Harris, L.S., ed.). US Government Printing Office, Washington, DC.
8. Galloway, M. (1990) Regulation of dopamine and serotonin synthesis by acute administration of cocaine. Synapse 6, 63-72.
9. Grabowski, J., Rhoades, H., Elk, R., Schmitz, J., Davis, C., Creson, D. and Kirby, K. (1995) Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: two placebo-controlled and double-blind trials. J. Clin. Psychopharmacol. 15, 163-174.
10. Hamilton, M. (1959) The assessment of anxiety states by rating. Br. J. Med. Psychol. 32, 50-55.
11. Hamilton, M. (1960) A rating scale for depression. J. Neurol. Neurosurg. Psychiatr. 23, 56-62.
12. Hollander, E., Mullen, L., DeCaria, C., Skodol, A., Schneier, F., Liebowitz, M. and Klein, D. (1991) Obsessive compulsive disorder, depression, and fluoxetine. J. Clin. Psychiatr. 52, 418-422.
13. Jacob, P., Elias-Baker, B., Jones, R. and Benowitz, N. (1987) Determination of benzoylecgonine and cocaine in biologic fluids by automated gas chromatography. J. Chromatogr. 41, 277-286.
14. Jennrich, R. and Schluchter, M. (1986) Unbalanced repeated measures models with structured covariance matrices. Biometrics 42, 805-820.
15. Kleinman, P., Kang, S., Lipton, D., Woody, G., Kemp, J. and Millman, R. (1992) Retention of cocaine abusers in out-patient psychotherapy. Am. J. Drug Alcohol Abuse 18, 29-43.
16. Means, L., Small, M., Capone, D., Capone, T., Condren, R., Peterson. M. and Hayward, B. (1989) Client demographics and outcome in out-patient cocaine treatment. Int. J. Addict. 24, 765-783.
17. McLellan, A., Luborsky, L., Woody, G. and O'Brien, C. (1980) An improved diagnostic evaluation instrument for substance abuse patients: The Addiction Severity Index. J. Nerv. Ment. Dis. 168, 26-33.
18. Norman, T.R., Gupta, R.K., Burrows, G.D., Parker, G. and Judd, F.K. (1993) Relationship between antidepressant response and plasma concentrations of fluoxetine and norfluoxetine. Int. Clin. Psychopharmacol. 8, 25-29.
19. Perez-Arce, P., Carr, K. and Sorensen, J. (1993) Cultural issues in an out-patient program for stimulant abusers. J. Psychoactive Drugs 25, 35-44.
20. Pollack, M. and Rosenbaum, J. (1991) Fluoxetine treatment of cocaine abuse in heroin addicts. J. Clin. Psychiatr. 52, 31-33.
21. Richardson, N. and Roberts, D. (1991) Fluoxetine pretreatment reduces breaking points on a progressive ratio schedule reinforced by intravenous cocaine self-administration in the rat. Life Sci. 49, 833-840.
22. Ritz, M., Cohen, E. and Kuhar, M. (1990) Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study. Life Sci. 46, 635-645.
23. SAS Technical Report P-229, SAS/STAT Software: Changes and Enhancements (1992). SAS Institute Inc., Cary, NC.
24. Spitzer, R., Williams, J., Gibbon, M. and First, M. (1990) Structured Clinical Interview for DSM-III-R-Patient Edition (SCID-P, Version 1.0). American Psychiatric Press, Washington, DC.
25. Walsh, S., Preston, K.L., Sullivan, J.T., Fromme, R. and Bigelow, G. (1994) Fluoxetine alters the effects of intravenous cocaine in humans. J. Clin. Psychopharmacol. 14, 396-407.